Activity Search Results - Continuing Certification Directory

Search Results

50 results were found

Activity Type	CME Provider	Title	Credit Hours	Fee	End Date
Reset sort order
	JAMA Oncology	Emerging EGFR-Targeted Therapy in Head and Neck Cancer - A Review	1	Yes	9/25/2028
	JAMA Oncology	Endometrial Cancer Classification and Management in the Molecular Subtyping Era	1	Yes	10/10/2027
	JAMA Oncology	Enhancing Clinical Cancer Research Through Sharing of Data and Biospecimens	1	Yes	12/18/2028
	JAMA Oncology	Enlargement of Shoulder Muscles in an Older Man	1	Yes	3/20/2028
	JAMA Oncology	Extensive Oral Ulcerations After Stem Cell Transplant	1	Yes	3/12/2029
	JAMA Oncology	Externally Controlled Studies Using Real-World Data in Patients With Hematological Cancers - A Systematic Review	1	Yes	8/29/2027
	JAMA Oncology	Foot Lesions and Perianal Lump in an Adult Woman	1	Yes	6/18/2028
	JAMA Oncology	Guidelines for Next-Generation Sequencing in Sarcoma Diagnosis and Treatment - A Consensus Review	1	Yes	10/16/2028
	JAMA Oncology	Hairy Kidneys and Sclerotic Bone Lesions	1	Yes	10/24/2027
	JAMA Oncology	Heterogeneity of Residual Disease After Neoadjuvant Systemic Therapy in Breast Cancer - A Review	1	Yes	9/12/2027
	JAMA Oncology	Immune Checkpoint Inhibitor Therapy Before Nephrectomy for Locally Advanced and Metastatic Renal Cell Carcinoma - A Review	1	Yes	12/14/2026
	JAMA Oncology	Immune Checkpoint Inhibitor–Associated Cardiovascular Toxic Effects - International Cardio-Oncology Society Position Statement	1	Yes	11/13/2028
	JAMA Oncology	Immunotherapy Strategies After Immune Checkpoint Inhibitor Exposure in Renal Cell Carcinoma - A Review	1	Yes	3/27/2028
	JAMA Oncology	Initial Management of BRAF V600E-Variant Anaplastic Thyroid Cancer - The FAST Multidisciplinary Group Consensus Statement	1	Yes	7/11/2027
	JAMA Oncology	Lymphoma With a Skin Rash	1	Yes	6/6/2027
	JAMA Oncology	Management of Adult Acute Lymphoblastic Leukemia - A Review	1	Yes	5/1/2028
	JAMA Oncology	Metastatic Hormone-Sensitive Prostate Cancer and Combination Treatment Outcomes - A Review	1	Yes	5/9/2027
	JAMA Oncology	Molecular Testing for the World Health Organization Classification of Central Nervous System Tumors - A Review	1	Yes	12/26/2027
	JAMA Oncology	Neoadjuvant Immune Checkpoint Inhibitor Therapy for Localized Deficient Mismatch Repair Colorectal Cancer - A Review	1	Yes	9/7/2026
	JAMA Oncology	New Retroperitoneal Soft-Tissue Lesion in Multiple Myeloma	1	Yes	2/12/2029

Search Results

50 results were found

Provider: JAMA Oncology
Title: Emerging EGFR-Targeted Therapy in Head and Neck Cancer - A Review
Credit Hours: 1 | Fee: Yes | End Date: 9/25/2028

Provider: JAMA Oncology
Title: Endometrial Cancer Classification and Management in the Molecular Subtyping Era
Credit Hours: 1 | Fee: Yes | End Date: 10/10/2027

Provider: JAMA Oncology
Title: Enhancing Clinical Cancer Research Through Sharing of Data and Biospecimens
Credit Hours: 1 | Fee: Yes | End Date: 12/18/2028

Provider: JAMA Oncology
Title: Enlargement of Shoulder Muscles in an Older Man
Credit Hours: 1 | Fee: Yes | End Date: 3/20/2028

Provider: JAMA Oncology
Title: Extensive Oral Ulcerations After Stem Cell Transplant
Credit Hours: 1 | Fee: Yes | End Date: 3/12/2029

Provider: JAMA Oncology
Title: Externally Controlled Studies Using Real-World Data in Patients With Hematological Cancers - A Systematic Review
Credit Hours: 1 | Fee: Yes | End Date: 8/29/2027

Provider: JAMA Oncology
Title: Foot Lesions and Perianal Lump in an Adult Woman
Credit Hours: 1 | Fee: Yes | End Date: 6/18/2028

Provider: JAMA Oncology
Title: Guidelines for Next-Generation Sequencing in Sarcoma Diagnosis and Treatment - A Consensus Review
Credit Hours: 1 | Fee: Yes | End Date: 10/16/2028

Provider: JAMA Oncology
Title: Hairy Kidneys and Sclerotic Bone Lesions
Credit Hours: 1 | Fee: Yes | End Date: 10/24/2027

Provider: JAMA Oncology
Title: Heterogeneity of Residual Disease After Neoadjuvant Systemic Therapy in Breast Cancer - A Review
Credit Hours: 1 | Fee: Yes | End Date: 9/12/2027

Provider: JAMA Oncology
Title: Immune Checkpoint Inhibitor Therapy Before Nephrectomy for Locally Advanced and Metastatic Renal Cell Carcinoma - A Review
Credit Hours: 1 | Fee: Yes | End Date: 12/14/2026

Provider: JAMA Oncology
Title: Immune Checkpoint Inhibitor–Associated Cardiovascular Toxic Effects - International Cardio-Oncology Society Position Statement
Credit Hours: 1 | Fee: Yes | End Date: 11/13/2028

Provider: JAMA Oncology
Title: Immunotherapy Strategies After Immune Checkpoint Inhibitor Exposure in Renal Cell Carcinoma - A Review
Credit Hours: 1 | Fee: Yes | End Date: 3/27/2028

Provider: JAMA Oncology
Title: Initial Management of BRAF V600E-Variant Anaplastic Thyroid Cancer - The FAST Multidisciplinary Group Consensus Statement
Credit Hours: 1 | Fee: Yes | End Date: 7/11/2027

Provider: JAMA Oncology
Title: Lymphoma With a Skin Rash
Credit Hours: 1 | Fee: Yes | End Date: 6/6/2027

Provider: JAMA Oncology
Title: Management of Adult Acute Lymphoblastic Leukemia - A Review
Credit Hours: 1 | Fee: Yes | End Date: 5/1/2028

Provider: JAMA Oncology
Title: Metastatic Hormone-Sensitive Prostate Cancer and Combination Treatment Outcomes - A Review
Credit Hours: 1 | Fee: Yes | End Date: 5/9/2027

Provider: JAMA Oncology
Title: Molecular Testing for the World Health Organization Classification of Central Nervous System Tumors - A Review
Credit Hours: 1 | Fee: Yes | End Date: 12/26/2027

Provider: JAMA Oncology
Title: Neoadjuvant Immune Checkpoint Inhibitor Therapy for Localized Deficient Mismatch Repair Colorectal Cancer - A Review
Credit Hours: 1 | Fee: Yes | End Date: 9/7/2026

Provider: JAMA Oncology
Title: New Retroperitoneal Soft-Tissue Lesion in Multiple Myeloma
Credit Hours: 1 | Fee: Yes | End Date: 2/12/2029